Nuvo Pennsaid Mid-2006 Filing Planned Following Positive Phase III Results
This article was originally published in The Pink Sheet Daily
Executive Summary
The trial of the topical osteoarthritis therapy was designed to address questions raised in FDA’s August 2002 “not approvable” letter, Nuvo says.